Ευρωπαϊκή Ένωση - Σλοβενικά - EMA (European Medicines Agency)

theramex ireland limited - abaloparatide - osteoporosis, postmenopausal; osteoporosis - kalcij homeostaza - zdravljenje osteoporoze pri ženskah po menopavzi pri večjem tveganju zloma.

Ευρωπαϊκή Ένωση - Σλοβενικά - EMA (European Medicines Agency)

viatris limited - klopidogrel besilat - peripheral vascular diseases; stroke; myocardial infarction - antitrombotična sredstva - secondary prevention of atherothrombotic events clopidogrel is indicated in:adult patients suffering from myocardial infarction (from a few days until less than 35 days), ischemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease. adult patients suffering from acute coronary syndrome. non-st segment elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa). st segmentu višinskih akutni miokardni infarkt, v kombinaciji s asa v medicinsko zdravljenih bolnikih, ki izpolnjujejo pogoje za thrombolytic terapija. in patients with moderate to high-risk transient ischaemic attack (tia) or minor ischaemic stroke (is) clopidogrel in combination with asa is indicated in:adult patients with moderate to high-risk tia (abcd2 score ≥4) or minor is (nihss ≤3) within 24 hours of either the tia or is event. prevention of atherothrombotic and thromboembolic events in atrial fibrillation:in adult patients with atrial fibrillation who have at least one risk factor for vascular events, are not suitable for treatment with vitamin k antagonists (vka) and who have a low bleeding risk, clopidogrel is indicated in combination with asa for the prevention of atherothrombotic and thromboembolic events, including stroke. za nadaljnje informacije, prosimo, preberite razdelek 5.

Ευρωπαϊκή Ένωση - Σλοβενικά - EMA (European Medicines Agency)

krka, d.d., novo mesto - clopidogrel (as hydrochloride) - peripheral vascular diseases; stroke; myocardial infarction - antitrombotična sredstva - clopidogrel je navedeno pri odraslih za preprečevanje atherothrombotic dogodkov v:bolnike, ki trpijo za miokardni infarkt (od nekaj dni do manj kot 35 dni), ischaemic kap (od 7 dni do manj kot 6 mesecev) ali sedež periferne arterijske bolezni.

Ευρωπαϊκή Ένωση - Σλοβενικά - EMA (European Medicines Agency)

krka, d.d., novo mesto - clopidogrel (as hydrochloride) - peripheral vascular diseases; stroke; myocardial infarction - antitrombotična sredstva - sekundarno preprečevanje atherothrombotic eventsclopidogrel je navedeno v:izobraževanje odraslih bolnikih, ki trpijo za miokardni infarkt (od nekaj dni do manj kot 35days), ischaemic kap (od 7 dni do manj kot 6months) ali sedež periferne arterijske bolezni. za odrasle bolnike, ki trpijo za akutni koronarni sindrom:non-st segmentu višinskih akutni koronarni sindrom (nestabilna angina pektoris ali ne-q-val, miokardni infarkt), vključno z bolniki, ki opravljajo stent umestitev po perkutani koronarni intervenciji, v kombinaciji z acetilsalicilne kisline (asa). st segmentu višinskih akutni miokardni infarkt, v kombinaciji s asa v medicinsko zdravljenih bolnikih, ki izpolnjujejo pogoje za thrombolytic terapija. preprečevanje atherothrombotic in thromboembolic dogodkov v atrijska fibrillationin odraslih bolnikov z atrijsko fibrilacijo, ki imajo vsaj en dejavnik tveganja za žilne dogodke, niso primerni za zdravljenje z antagonisti vitamina k (vka) in ki imajo nizko tveganje krvavitve, clopidogrel je indiciran v kombinaciji s asa za preprečevanje atherothrombotic in thromboembolic dogodkov, vključno z možgansko kap.

Ευρωπαϊκή Ένωση - Σλοβενικά - EMA (European Medicines Agency)

taw pharma (ireland) limited - klopidogrel hidroklorid - peripheral vascular diseases; stroke; myocardial infarction; acute coronary syndrome - antitrombotična sredstva - , , , , secondary prevention of atherothrombotic events, , clopidogrel is indicated in: , - adult patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease. , - adult patients suffering from acute coronary syndrome:,    - non-st segment elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa). ,     - st segment elevation acute myocardial infarction, in combination with asa in medically treated patients eligible for thrombolytic therapy. , , in patients with moderate to high-risk transient ischaemic attack (tia) or minor ischaemic stroke (is), clopidogrel in combination with asa is indicated in:, - adult patients with moderate to high-risk tia (abcd2  score ≥4) or minor is (nihss  ≤3) within 24 hours of either the tia or is event.  , , prevention of atherothrombotic and thromboembolic events in atrial fibrillation, in adult patients with atrial fibrillation who have at least one risk factor for vascular events, are not suitable for treatment with vitamin k antagonists (vka) and who have a low bleeding risk, clopidogrel is indicated in combination with asa for the prevention of atherothrombotic and thromboembolic events, including stroke. , , for further information please refer to section 5. , , ,.

Ευρωπαϊκή Ένωση - Σλοβενικά - EMA (European Medicines Agency)

tad pharma gmbh - clopidogrel (as hydrochloride) - peripheral vascular diseases; stroke; myocardial infarction - antitrombotična sredstva - clopidogrel is indicated in adults for the prevention of atherothrombotic events in: , patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease.

Ευρωπαϊκή Ένωση - Σλοβενικά - EMA (European Medicines Agency)

eisai gmbh - alitretinoin - sarcoma, kaposi - antineoplastična sredstva - panretin gel je navedena za lokalno zdravljenje kožne lezije pri bolnikih s pridobljenim-imunski-pomanjkljivosti-sindrom (aids), povezanih z kaposi ' s sarkom (ks), če:so poškodbe, ki niso ulcerated ali lymphoedematous, in;zdravljenje globokih ks, ni potrebno, in;poškodbe se ne odziva na sistemski antiretrovirusne terapije, in;naprave za radioterapijo ali kemoterapijo niso primerne.

Ευρωπαϊκή Ένωση - Σλοβενικά - EMA (European Medicines Agency)

krka, d.d., novo mesto - clopidogrel (as hydrogen sulfate) - peripheral vascular diseases; stroke; acute coronary syndrome; myocardial infarction - antitrombotična sredstva - preprečevanje sekundarno preprečevanje atherothrombotic dogodkov clopidogrel je navedeno v:izobraževanje odraslih bolnikih, ki trpijo za miokardni infarkt (od nekaj dni do manj kot 35 dni), ischaemic kap (od 7 dni do manj kot 6 mesecev) ali sedež periferne arterijske bolezni. za odrasle bolnike, ki trpijo za akutni koronarni sindrom:- niso-st segmentu višinskih akutni koronarni sindrom (nestabilna angina pektoris ali ne-q-val, miokardni infarkt), vključno z bolniki, ki opravljajo stent umestitev po perkutani koronarni intervenciji, v kombinaciji z acetilsalicilne kisline (asa). - st segmentu višinskih akutni miokardni infarkt, v kombinaciji s asa v medicinsko zdravljenih bolnikih, ki izpolnjujejo pogoje za thrombolytic terapija. preprečevanje atherothrombotic in thromboembolic dogodkov v atrijsko fibrilacijo:- v izobraževanje bolnikov z atrijsko fibrilacijo, ki imajo vsaj en dejavnik tveganja za žilne dogodke, niso primerni za zdravljenje z antagonisti vitamina k (vka) in ki imajo nizko tveganje krvavitve, clopidogrel je indiciran v kombinaciji s asa za preprečevanje atherothrombotic in thromboembolic dogodkov, vključno z možgansko kap.

Σλοβενία - Σλοβενικά - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

lek d.d. - alendronska kislina - filmsko obložena tableta in šumeča tableta - alendronska kislina 70 mg / 1 tableta - alendronska kislina, kalcij in holekalciferol, zaporedni

Σλοβενία - Σλοβενικά - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

askorbinska kislina (vitamin c); biotin (vitamin h); cianokobalamin (vitamin b12); folna kislina (vitamin b9); holekalciferol (vitamin d3); riboflavin (vitamin b2); vseracemni-alfa-tokoferol (vitamin e); vitamin a; piridoksin (vitamin b6); tiamin (vitamin b1); pantotenska kislina (vitamin b5); nikotinamid (vitamin b3); fitomenadion, vseracemni - prašek za raztopino za infundiranje - askorbinska kislina (vitamin c) 200 mg / 1 viala  biotin (vitamin h)0,06 mg / 1 viala  cianokobalamin (vitamin b12)0,005 mg / 1 viala  folna kislina (vitamin b9)0,6 mg / 1 viala  holekalciferol (vitamin d3)0,005 mg / 1 viala  riboflavin (vitamin b2)3,6 mg / 1 viala  vseracemni-alfa-tokoferol (vitamin e)9,11 mg / 1 viala  vitamin a0,99 mg / 1 viala  piridoksin (vitamin b6)6 mg / 1 viala  tiamin (vitamin b1)6 mg / 1 viala  pantotenska kislina (vitamin b5)15 mg / 1 viala  nikotinamid (vitamin b3)40 mg / 1 viala  fitomenadion, vseracemni0,15 mg / 1 viala; biotin (vitamin h) 0,06 mg / 1 viala  cianokobalamin (vitamin b12)0,005 mg / 1 viala  folna kislina (vitamin b9)0,6 mg / 1 viala  holekalciferol (vitamin d3)0,005 mg / 1 viala  riboflavin (vitamin b2)3,6 mg / 1 viala  vseracemni-alfa-tokoferol (vitamin e)9,11 mg / 1 viala  vitamin a0,99 mg / 1 viala  piridoksin (vitamin b6)6 mg / 1 viala  tiamin (vitamin b1)6 mg / 1 viala  pantotenska kislina (vitamin b5)15 mg / 1 viala  nikotinamid (vitamin b3)40 mg / 1 viala  fitomenadion, vseracemni0,15 mg / 1 viala; cianokobalamin (vitamin b12) 0,005 mg / 1 viala  folna kislina (vitamin b9)0,6 mg / 1 viala  holekalciferol (vitamin d3)0,005 mg / 1 viala  riboflavin (vitamin b2)3,6 mg / 1 viala  vseracemni-alfa-tokoferol (vitamin e)9,11 mg / 1 viala  vitamin a0,99 mg / 1 viala  piridoksin (vitamin b6)6 mg / 1 viala  tiamin (vitamin b1)6 mg / 1 viala  pantotenska kislina (vitamin b5)15 mg / 1 viala  nikotinamid (vitamin b3)40 mg / 1 viala  fitomenadion, vseracemni0,15 mg / 1 viala; folna kislina (vitamin b9) 0,6 mg / 1 viala  holekalciferol (vitamin d3)0,005 mg / 1 viala  riboflavin (vitamin b2)3,6 mg / 1 viala  vseracemni-alfa-tokoferol (vitamin e)9,11 mg / 1 viala  vitamin a0,99 mg / 1 viala  piridoksin (vitamin b6)6 mg / 1 viala  tiamin (vitamin - vitamini